✦ LIBER ✦

PND37 The Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) for the Treatment of Acute Epileptic Seizures in the UK; a Hybrid Model Solution

✍ Scribed by Lee, D.; Batty, A.; Gladwell, D.; Brereton, N.J.; Tate, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND15 Cost-Effectiveness of Buccolam® (L

✍ Lee, D.; Gladwell, D.; Batty, A.; Brereton, N.J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND41 The Cost-Effectiveness of Buccolam

✍ Lopez-Bastida, J.; Gil Aguirre, A.; Lee, D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

P78 – 1596 The cost effectiveness of mid

✍ Lee, D; Porter, J; Tate, E; Saunders, A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Buccolam® (buccal midazolam): a review o

✍ Jevon, P. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

A comparison of the cost-effectiveness o

✍ Lee, Dawn C; Gladwell, Daniel; Hatswell, Anthony J; Porter, Joshua; Brereton, Ni 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 773 KB

PND11 Lacosamide for the Treatment of Pa

✍ Makarounas-Kichmann, K.; Kirchmann, M.; Monin, N. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB